✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹21 Cr.
P/E
59.54
About
Bacil Pharma Limited, incorporated in the year 1987, is a public limited company. The main object of the Company is to undertake Pharmaceutical business. The company manufactures bulk pharmaceutical/ … Read more
Bacil Pharma Limited, incorporated in the year 1987, is a public limited company. The main obj… Read more
Low
12
52W Range
High
63
  • Bacil Pharma
  • Phaarmasia
  • Ishita Drugs & Inds.

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

0 Neutral

Neutral for this company

7 No

Negative for this company

5 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Bacil Pharma Ltd. Business

Established in 1987, Bacil Pharma Limited is a public company specializing in bulk pharmaceutical and chemical manufacturing, including heavy, medium, and fine chemicals.

Bacil Pharma major competitors are Phaarmasia, Ishita Drugs & Inds., Adeshwar Meditex, Saroja Pharma Ind, Norris Medicines, Hamps Bio, Kabra Drugs.
Market Cap of Bacil Pharma is ₹21 Crs.
While the median market cap of its peers are ₹23 Crs.

Bacil Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Bacil Pharma is 0 and is ranked 6 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material